Status:
COMPLETED
Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification
Lead Sponsor:
Medical University of Vienna
Conditions:
Cataract
Pseudophakia
Eligibility:
All Genders
40+ years
Phase:
PHASE4
Brief Summary
Purpose: To compare the posterior capsule opacification (PCO) inhibiting effect of the sharp posterior optic edge design of the Clariflex silicone intraocular lens (IOL) with that of the double-round ...
Eligibility Criteria
Inclusion
- bilateral, age related cataract
Exclusion
- history of other ocular disease or intraocular surgery
- diabetes requiring medical control
Key Trial Info
Start Date :
June 1 2001
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00428363
Start Date
June 1 2001
End Date
March 1 2006
Last Update
January 30 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Ophthalmology, Medical University of Vienna
Vienna, Vienna, Austria, 1090